BATS BZX Real-Time Price
As of 2:49pm ET
| -4.43 / -3.80%|
The 18 analysts offering 12-month price forecasts for Celgene have a median target of 151.00, with a high estimate of 190.00 and a low estimate of 93.00. The median estimate represents a +34.59% increase from the last price of 112.19.
The current consensus among 22 polled investment analysts is to Buy stock in Celgene. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.